dcsimg

Kathleen H. Dooley

Partner

Related Content

Practices
Industries
Education
  • Seton Hall University School of Law, JD, cum laude, Articles Editor, Seton Hall Law Review, 1988
  • Seton Hall University, BA, 1981
Admissions
  • North Carolina
  • Pennsylvania
  • New Jersey
  • U.S. Supreme Court
  • North Carolina Supreme Court
  • U.S. District Court for the Eastern District of New York
  • U.S. District Court for the Southern District of New York
  • U.S. District Court for the Northern District of New York
  • U.S. District Court for the District of New Jersey
  • U.S. District Court for the Eastern District of Virginia
  • U.S. District Court for the Western District of North Carolina
  • U.S. District Court for the Eastern District of North Carolina
  • U.S. District Court for the Middle District of North Carolina
  • U.S. Court of Appeals for the 11th Circuit
  • U.S. Court of Appeals for the 5th Circuit
  • U.S. Court of Appeals for the 3rd Circuit
  • Supreme Court of Pennsylvania
  • Supreme Court of New Jersey
Affiliations

Member, International Association of Defense Counsel

Member, Mecklenburg County Bar Association

Member, North Carolina Bar Association

Member, North Carolina Association of Women Attorneys

Member, North Carolina Association of Defense Attorneys

Member, American Bar Association

Parishioner and Finance Committee Member, All Saints Catholic Church

Print

Kathleen is a courtroom litigator and counselor and co-chair of the firm's global Life Sciences Industry Group. For 25 years, she has enjoyed the diversity of her civil litigation career through representation of diverse business entities such as consumer finance and financial services providers, communications providers, pharmaceutical and medical device companies, healthcare companies, and entertainment facilities involved in complex disputes. Kathleen also provides counsel to corporate policyholders in a variety of insurance first- and third-party coverage-related disputes and litigation, including environmental, property, products liability, professional liability, business interruption, and directors and officers. She also litigates extra-contractual disputes and frequently provides insurance-related due diligence counsel in corporate transactions.

Her experience includes, but has not been limited to, litigating business and consumer credit disputes, class actions, civil RICO, pharmaceutical/medical device/consumer product diversion, unfair and deceptive trade practices, bad faith, intellectual property, products liability, and labor and employment matters. Clients frequently call on her to handle matters pending in jurisdictions where juries are hostile to corporate defendants, and so she has represented clients in Arkansas, Mississippi, Florida, North Carolina, Kentucky, Nebraska, New York, New Jersey, South Carolina, Texas and Virginia. Her experience also includes serving as law clerk to the Honorable Melvin P. Antell, P.J.A.D. of the Superior Court of New Jersey, Appellate Division. Kathleen has also served as an adjunct profession for law school legal research and writing classes.

Kathleen is also certified as a Healthcare Compliance professional.

vCard
T: +1 704 343 2347F: +1 704 444 8755kdooley@mcguirewoods.com201 North Tryon Street
Suite 3000
Charlotte, NC 28202-2146

Obtained dismissals of multi-jurisdictional federal court class actions brought against major credit card issuer.

Obtained dismissal of class action against credit card issuer arising out of credit card protection plan features.

Effectively investigated and prosecuted numerous federal and state court cases against  gray marketers of pharmaceutical, medical device and consumer products.

Representation of tire valve manufacturer seeking coverage from its liability insurer

Representation of lithium manufacturer successfully refuting workers compensation insurer’s attempt to impose liability for claims not assumed in post-merger agreement.

Co-author, "Pharmaceutical Product Diversion: An Ounce of Prevention is a Cure for Compliance," Pharmaceutical Compliance Monitor, May 9, 2012
Co-author, "Analysis of Pharmaceutical Product Diversion and the Gray Market: Cheaper Drugs but as What Cost," Health Care Law Monthly, September 2010
Speaker, "Legal Risks in the Sales and Marketing of Medical Devices Conference," ACI, April 29, 2011
Speaker, "Legal Strategies for Contract Enforcement and Brand Protection," NADDI Western Regional Conference, April 28, 2011
Speaker, Pharmaceutical Product Diversity: Beyond the PDMA, October 3, 2010
Speaker, National Bar Association Health Law Section Summit, 2009
Speaker, NBI – Insurance Coverage Litigation Conference, December 2009
Speaker, "How to Prevent, Detect, Investigate & Deter Diversion," Pathway to Counterfeiting, June 26, 2009